Literature DB >> 8568476

Leukaemia inhibitory factor in human endometrium throughout the menstrual cycle.

D Vogiagis1, M M Marsh, R C Fry, L A Salamonsen.   

Abstract

Leukaemia inhibitory factor (LIF) is a pleiotropic cytokine previously demonstrated to be essential for blastocyst implantation in mice. Samples of endometrium from normal cyclic women throughout the menstrual cycle were tested for LIF messenger RNA by Northern blot analysis and the corresponding protein was localised immunohistochemically with a polyclonal antibody to LIF. Western blot analysis detected a 45 kDa LIF protein in an extract from late secretory tissue. The expression of LIF messenger RNA transcript was detected only during the mid and late secretory phases of the cycle after day 20. Immunoreactive LIF was observed in all human endometrial samples. In the stroma there were moderate to high levels of immunohistochemical staining throughout the cycle with considerable variation between individuals but no cyclical variation. Epithelial staining, both luminal and glandular, was also present throughout the cycle but this was relatively low in the proliferative phase and strongest in the mid to late secretory phases. The marked cyclical changes of immunoreactive LIF in the human endometrial epithelium suggest a paracrine/autocrine role for LIF in endometrial function. Whether LIF is essential for implantation in the human remains to be established.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8568476     DOI: 10.1677/joe.0.1480095

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  14 in total

1.  Birth control vaccine targeting leukemia inhibitory factor.

Authors:  Angela R Lemons; Rajesh K Naz
Journal:  Mol Reprod Dev       Date:  2011-12-02       Impact factor: 2.609

Review 2.  Role of the leukemia-inhibitory factor gene mutations in infertile women: the embryo-endometrial cytokine cross talk during implantation--a delicate homeostatic equilibrium.

Authors:  M Králícková; P Síma; Z Rokyta
Journal:  Folia Microbiol (Praha)       Date:  2005       Impact factor: 2.099

3.  Uterine deletion of Gp130 or Stat3 shows implantation failure with increased estrogenic responses.

Authors:  Xiaofei Sun; Amanda Bartos; Jeffrey A Whitsett; Sudhansu K Dey
Journal:  Mol Endocrinol       Date:  2013-07-24

4.  Reduced uterine receptivity for mouse embryos developed from in-vitro matured oocytes.

Authors:  Yu-Hung Lin; Ching-Yen Tsai; Lee-Wen Huang; Kok-Min Seow; Jiann-Loung Hwang; Chii-Ruey Tzeng
Journal:  J Assist Reprod Genet       Date:  2014-10-08       Impact factor: 3.412

5.  Leukemia inhibitory factor expression in different endometrial locations between fertile and infertile women throughout different menstrual phases.

Authors:  H D Tsai; C C Chang; Y Y Hsieh; H Y Lo
Journal:  J Assist Reprod Genet       Date:  2000-09       Impact factor: 3.412

6.  Population pharmacokinetic modelling of Emfilermin (recombinant human leukaemia inhibitory factor, r-hLIF) in healthy postmenopausal women and in infertile patients undergoing in vitro fertilization and embryo transfer.

Authors:  Timothy Goggin; Quyen T X Nguyen; Alain Munafo
Journal:  Br J Clin Pharmacol       Date:  2004-05       Impact factor: 4.335

7.  Blocking LIF action in the uterus by using a PEGylated antagonist prevents implantation: a nonhormonal contraceptive strategy.

Authors:  Christine A White; Jian-Guo Zhang; Lois A Salamonsen; Manuel Baca; W Douglas Fairlie; Donald Metcalf; Nicos A Nicola; Lorraine Robb; Evdokia Dimitriadis
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-27       Impact factor: 11.205

Review 8.  The role of growth factors and cytokines during implantation: endocrine and paracrine interactions.

Authors:  Ozlem Guzeloglu-Kayisli; Umit Ali Kayisli; Hugh S Taylor
Journal:  Semin Reprod Med       Date:  2009-02-05       Impact factor: 1.303

9.  A peptide derived from the human leptin molecule is a potent inhibitor of the leptin receptor function in rabbit endometrial cells.

Authors:  Ruben Rene Gonzalez; Paul C Leavis
Journal:  Endocrine       Date:  2003-07       Impact factor: 3.633

10.  Prokineticin 1 mediates fetal-maternal dialogue regulating endometrial leukemia inhibitory factor.

Authors:  Jemma Evans; Rob D Catalano; Pamela Brown; Rob Sherwin; Hilary O D Critchley; Asgerally T Fazleabas; Henry N Jabbour
Journal:  FASEB J       Date:  2009-03-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.